• Visit the new and improved OGS website for all your grant related needs. Direct all your pre-award inquiries to the Einstein-OGS team at [email protected].

  • OGS is organizing Cayuse training sessions in-person on a monthly basis in the library training room. This hands-on training session is by invitation only. Please send your email request to [email protected] if you would like to participate.

  • ALL proposals (both federal and non-federal, including limited submissions and private foundations) must be reviewed and approved by OGS first in Cayuse before final submission to the funding agencies.

  • Select Indranil Basu as SO, BO or AOR as you find on the drop-down menu of the grant application portals. For DOD proposals, select Dr. Basu's name on both #5 and #19 in Cayuse SF424RR.

  • DMS Plan review requests can be made to Dr. Indranil Basu at least 3 days before the grant deadline. Make sure to address all 6 elements without any URLs or hyperlinks. The NIH and DOD DMS plan templates are available on request.
  • For NIH: In the SF424RR, page 2, #14, the Division should be: Albert Einstein College of Medicine. We have new instructions from the eRA commons helpdesk that this is needed in order for the PI Department to populate in eRA Commons and the NIH RePORTER.

  • For Proposal Central: Select Indranil Basu as Grants Officer (Signing Official, Authorized Institution Official Representative), Suzanne Locke as Fiscal Officer and Janis Paradiso as Technology Transfer Officer.

  • OHRA still requires a reliance request for studies being reviewed by BRANY (except for those that are industry funded and qualify for BRANY’s industry fast-track designation) as decisions related to a single IRB review of research (whether Einstein IRB is reviewing or relying) are made by OHRA on a protocol-specific, case-by-case basis. The reliance requests are required to be submitted at least 10 days in advance of any grant deadlines. If a reliance request has not yet been submitted, please submit one by using this link.

  • We strongly advise submitting the applications to funding agencies at least 24 - 48 hours before the sponsor deadline.

Important links, forms and documents

The Federal Wide Assurance (FWA) is the institution's commitment to comply with federal regulations for the protection of human subjects in research. Please find Einstein's FWA# here.

Please use the PI Certification form if the PIs choose not to certify the proposal directly in Cayuse SP.

The guidance and the institutional certification form for genomic data sharing policy can be found here.

Want to create a new eRA Commons Account? Please fill out the request form available here.

Grant.gov upcoming Maintenance: December 16-18, 2023 and January 20-22. 2024

The Grants.gov Program Management Office (PMO) schedules system-wide software releases to bring its users new features and fixes. During these releases, downtime will be scheduled to deploy new enhancements. The PMO also performs scheduled maintenance on its databases and Websites in order to provide enhanced IT security and increased network reliability. The Grants.gov Calendar lists anticipated dates for both system-wide enhancements and scheduled downtimes for system maintenance.

Read More

NIH Updates

Weekly NIH Funding Opportunities and Notices - 2023

Please click the dates below to find out the NIH funding opportunities November 24, December 01, December 08, and December 15.

Types of Letters for Grant Applications

Learn when and how to submit a reference letter, cover letter, letter of intent, letter of support and other documents. Each key letter has a distinct purpose in informing peer reviewers, NIH staff, or both. Certain letters may be necessary while others are optional or should be left out, depending on your research plans and the type of your application. The subpages contain instructions on how to use each type of letter and what is required.

Read More

NCI SBIR/STTR Omnibus Grant Solicitations

SBIR/STTR Omnibus Solicitations are intended to support small business innovation research across a broad spectrum of topic areas. For the full program description and research topics, please read the 2023 Omnibus Solicitation Program Description.

Read More

NOT-OD-24-029: Clarification of Implementation of the NIH SBIR and STTR Foreign Disclosure Pre-award and Post-Award Requirements

11/14/23: The purpose of this Notice is to provide clarification regarding findings of foreign involvement with countries of concern related to grants and cooperative agreements. The specific changes implemented in NOT-OD-23-139 and clarified in the current Notice apply to all competing applications for funding under the NIH, CDC, and FDA SBIR and STTR programs submitted for due dates on or after September 5, 2023.

Read More

NOT-OD-23-185: Prior Approval Requests for Revisions to an Approved Data Management and Sharing (DMS) Plan Must be Submitted Using the Prior Approval Module

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Prior approval requests for revisions to an approved data management and sharing (DMS) plan must be submitted timely to the funding NIH Institute, Center, or Office (ICO). This functionality for NIH grants is effective from October 12, 2023, and will be used exclusively for submitting requests for updating the DMS Plan. Emails and other communications are not acceptable.

Read More

Update on Improving NRSA Fellowship Review: Analysis of Comments from the Request for Information

NIH has received feedback from the community in response to their request for information on the proposed changes to the peer review of Ruth L. Kirschstein National Research Service Award (NRSA) fellowship applications. The blog summarizes the feedback on restructuring the review criteria and modifying some sections of the PHS Fellowship Supplemental Form that are specific to NRSAs.

Read More

Beginning October 23, 2023, NSF will require all Biosketch and Current and Pending documents to be created in SciENcv. Please refer to NSF’s FAQs on how to sign-in to SciENcv and prepare key personnel documents. Find some reference materials (links below) regarding the SciENcv information, helpful in populating NSF or NIH biosketches and/or NSF current and pending support as well: -

Click the video and slide deck links.

FY24 Pre-announcement released

Although FY24 funds have not been appropriated, CDMRP is providing information

to allow investigators time to plan and develop ideas for submission to the anticipated FY24 funding opportunities.

The Peer Reviewed Epilepsy Research Program (ERP) released a pre-announcement for the following funding opportunities: 

  • Leveraging Research Award
  • Virtual Post-Traumatic Epilepsy Research Center (P-TERC) – Faulty Award

o  Early-career investigators and investigators new to the PTE field may be named as principal investigator on applications to this funding opportunity

  • Idea Development Award

o  Early-career investigators ranging from the post-doctoral level (e.g., research associate, fellows, residents, or equivalent) to within 3 years of their first independent faculty position may be named as PI on applications to funding level one within this funding opportunity

  • Research Partnership Award
Read More

Non-Federal Funding Opportunities

Evidence for Action: Innovative Research to Advance Racial Equity

Evidence for Action (E4A) prioritizes research to evaluate specific interventions to counteract the harms of structural and system racism and improve health, well-being, and equity outcomes. The foundation is also interested in direct impacts of structural racism on health plus ways in which racism intersects with other forms of marginalization, such as having low income, being an immigrant, having a disability, or identifying as LGBTQ+ or a gender minority. This funding is geared toward studies about “upstream” causes of health inequities, such as the systems, structures, laws, policies, norms, and practices that determine the distribution of resources and opportunities, which in turn influence individuals’ options and behaviors. Priority is given to studies of interventions that are designed to reduce race-based disparities. we prioritize studies of interventions that are designed to reduce race-based disparities. As an investigator-initiated program, E4A does not pose a specific set of research questions, topics, or categories for funding. In general, research funded by E4A should apply a racial equity “lens” in both its topic and approach. This means that research topics center the health priorities of people or communities that have been impacted by structural racism; that problems and solutions being studied are motivated and/or validated by people who are directly impacted; and that the research process engages stakeholders at appropriate stages of the project.

Eligibility: Anyone may be designated as the PI. The PI does not need to hold an advanced degree nor need to be considered a "researcher" for the project. Lead PI must be based in US. Expertise of academic researchers, practitioners, and individuals or groups with issue-specific knowledge and experiences are integrated at appropriate stages of the project; community members, advocates, policymakers, and/or other stakeholders are engaged equitably and meaningfully

Deadline: December 22 @ 3pm (also accepting applications on a rolling basis)

Amount: Varies: Generally, $500k-$600k/3 years

Link: E4A RFP

Contact: Audrey McInerney ([email protected]) for more information or assistance.

Read More

NYSCF – Druckenmiller Advanced Postdoctoral Fellowship Awards

The NYSCF Druckenmiller Advanced Postdoctoral Fellowship is designed to encourage candidates at later stages of their postdoctoral training before transitioning to an independent faculty position, and will be awarded for 1 year. (Candidates in earlier stages are invited to consider the Early Postdoctoral Fellowship.) The fellowship provides an annual stipend of $62,400 plus $2,500 for computer and travel expenses. Learn more and find out how to apply at: nyscf.org/fellowshipaward

All applications must be submitted through the online portal before 5:00 PM EST on January 10, 2024 to be put forward for review. Please refer to the RFA and our website for additional details.

Read More

NYSCF – Druckenmiller Early Postdoctoral Fellowship Awards

NYSCF invites applications from postdoctoral fellows at institutions within New York, New Jersey, and Connecticut for awards to support translational stem cell research. Designed to attract promising candidates who are generally within the first four years of postdoctoral experience and looking for up to three years of postdoctoral support.The fellowship provides an annual stipend of $62,400 plus $2,500 for computer and travel expenses. Learn more and find out how to apply at: nyscf.org/fellowshipaward

All applications must be submitted through the online portal before 5:00 PM EST on January 10, 2024 to be put forward for review. Please refer to the RFA and our website for additional details.

Read More

SCPAB Transition to Independence Award | Simons Foundation

For postdoctoral fellows from diverse and/or historically underrepresented backgrounds to pursue research in cognitive aging and facilitates their transition into independent faculty positions at research institutions within or outside the United States. A previous background in aging research is not required; candidates with a background in fields including neuroscience, molecular biology, genetics, immunology, cell biology, and the physical and information sciences are encouraged to apply. Applicants must focus their scientific proposal on their future lab and independent research program plans, not the remainder of their postdoctoral position. Fellows will receive up to two years of postdoctoral fellowship support during their job search, with an annual salary of $85,000, fringe benefits, an annual resource and professional development allowance of $10,000, and indirect costs followed by a commitment of $600,000 over three years, including indirect costs, activated upon assumption of a tenure-track research professorship.

Eligibility: The program is aimed at PhD and/or MD-holding scientists from diverse and/or historically underrepresented groups in science who are currently in a non-independent, mentored training position at an institution within or outside the U.S. and who will be actively seeking and applying to tenure-track faculty positions between September 2024 and May 2025. 

Deadline: January 10, 2024

Link: SCPAB Transition to Independence Award

Contact: Audrey McInerney ([email protected]) for more information and/or assistance.

Read More

CRI Lloyd J. Old STAR Program – Applications due January 15.

Long-term funding for mid-career scientists pursuing high-risk, high-reward research at the forefront of discovery and innovation in cancer immunotherapy. CRI STARs are expected to be the future leaders in the field. STARs receive $1.25M over five years.

Click here to find all the CRI funding opportunities.

2024 Research Supplement to Promote Diversity in Science

The purpose of this award is to enable current AHA awardees to identify and serve as mentors for pre and Postdoctoral fellows from underrepresented racial and ethnic groups in science and medicine. A maximum of two years of AHA support will be provided per trainee. The annual Stipend will match the NIH scale for pre and postdoctoral fellows. AHA does not pay indirect costs for fellowships. The proposal deadline is January 17, 2024 (3 pm CT). For eligibility criteria, budget, restrictions, required application documents, peer review criteria and other details, please click here.

Read More

Postdoctoral Diversity Enrichment Program - Burroughs Wellcome Fund

The Burroughs Wellcome Fund (BWF) Postdoc and Career Development Funding Opportunities BWF is accepting applications for its Postdoctoral Diversity Enrichment Program. Due Jan. 18, 2024 (3 pm ET), the awards “provides a total of $60,000 over three years to support the career development activities for underrepresented minority postdoctoral fellows in a degree-granting institution whose training and professional development are guided by mentors committed to helping them advance to stellar careers in biomedical or medical research.” Eligibility requirements are here. Please note that there is a US citizenship requirement for this award.

Read More

Edward P. Evans Foundation MDS Young Investigator Award

This transition award is for senior trainees looking to move to an independent investigator position in Myelodysplastic Syndromes Research. The grant is for promising candidates committed to the study of the biology, pathogenesis, and treatment of MDS. Recognizing that securing independent funding is often challenging during this period of career development, the goal is to facilitate this transition and promote the entry of new investigators into the MDS field. Eligible candidates include outstanding researchers conducting innovative research under the guidance of an established Mentor. Candidates must demonstrate how this funding, for the limited period of the award, will help to advance their project, idea, or research laboratory to the point of securing an independent investigator position.

Eligibility: Candidate should be an early career (typically within 8 years of completing a graduate degree) physician or scientist (MD, PhD, or MD-PhD), currently in a non-tenure track (or equivalent) position. Eligible candidates generally should not hold the title of Assistant Professor and may not hold the title of Associate Professor or Professor. Individuals who are presently, or have in the past, been the PI on any government or privately funded research grant (except for an NIH training grant or similar) are not eligible. Candidate Mentors should be nationally recognized active investigators working at the cutting edge of basic, translational, or clinical research in MDS.

Deadline: January 31, 2024

Amount: $450k/3 years

Link: MDS Young Investigator Award RFP

Contact: Audrey McInerney ([email protected]) for more information and/or assistance.

Read More

Edward P. Evans Foundation Discovery Research Grant

This grant is to address critical challenges in Myelodysplastic Syndromes. The following topics are of specific interest. Please note these are only suggestions - we are most interested in whatever your most exciting ideas might be: progression of clonal hematopoiesis to MDS and on to AML; preclinical models for the practical discovery and development of new MDS therapies; germline mutations predisposing patients to MDS, age-associated clonal hematopoiesis or genetic mosaicism; large scale screening and molecular modeling against existing targets for the development of new MDS therapies; novel cell-based therapies or bone marrow transplants; correlative research to better understand, direct, or clarify the impact of clinical studies showing significant promise for MDS treatment; data sources for the application of machine learning to MDS analyses; novel imaging modalities and algorithms for improving diagnosis, understanding pathogenesis, and directing therapy; models of disease based upon patient data, covering all, or a portion of, the progression from clonal hematopoiesis to AML.

Eligibility: Applicants must be established independent investigators in a tenure-track or tenured position at the Assistant Professor level (or equivalent), or higher. Investigators previously funded by the Foundation are welcome to apply. Investigators who are currently funded may apply in their final year of funding.

LOI Deadline: January 31, 2024

Amount: $750k/3 years

Link: MDS Discovery Research Grant RFP

Contact: Audrey McInerney ([email protected]) for more information and/or assistance.

Read More

2024 Transformational Project Award

The purpose of this award is to support highly innovative, high-impact projects leading to critical discoveries or major advancements in the field of cardiovascular and/or cerebrovascular research. The annual award amount is $100,000, including 10 percent indirect cost. Duration of this award will be three years with a total award amount of $300,000. The proposal deadline is February 15, 2024 (3 pm CT). For eligibility criteria, restrictions, peer review criteria and other details, please click here.

Read More

Young Investigator Award

The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications in all areas of cancer research are accepted from U.S. and international applicants. The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants who are selected to receive a YIA are allowed to receive other grants from other funding agencies. The details of eligibility, application instructions and applicable due dates (January 31 and March 14, 2024) can be found here.

Read More

Distinguished Scientist Award | The Sontag Foundation

The Sontag Foundation, Ponte Vedra Beach, Florida, is one of the largest private funders of brain cancer research in North America. The Foundation is soliciting applications for its Distinguished Scientist Award. $750,000 in funding over 5 years is open to early career investigators throughout the United States. The goal of this funding initiative is to change the paradigm of brain cancer research by building a community of outstanding scientists whose pioneering approaches have the potential to make significant advances in the field of brain cancer/brain tumors. The applications are due on March 13, 2024 at 11:59pm ET. Please click here to find the grant guidelines.

Eligibility - Applicants must hold a doctoral degree in a discipline with applicability to brain cancer research. Applicants must have received their first independent faculty appointment no earlier than March 1, 2019 and no later than January 1, 2024 at a tax-exempt academic, research, or medical institution within the United States or an equivalent institution in Canada. If the institution grants tenure, the qualifying appointment must be on tenure track. More than one individual from the same institution may apply for this award. This grant does not support clinical trials research. For further inquiries, please contact Shandra Koler, Senior Program Officer, Email: [email protected] and phone: 904-274-8557.

Read More

Career Development Award

The Career Development Award (CDA) provides research funding to clinical investigators who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Applications in all areas of cancer research are accepted from U.S. and international applicants.The CDA is a three-year grant totaling $200,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants and Awards Ceremony at the ASCO Annual Meeting. The details of eligibility, application instructions and applicable due date (March 14, 2024) can be found here.

Read More

Please note the new OGS email address: OGS@einsteinmed.edu